Â鶹´«Ã½

Skip to main content

Paxlovid medication lowers risk of COVID-19 death, hospitalization: study

Share

A new has found that Paxlovid is proven to lower the risk of COVID-19-related death and hospitalization among those likely to experience severe illness.

Paxlovid, which is the brand name for the drug nirmatrelvir–ritonavir, is an antiviral medication used to treat mild to moderate cases of COVID-19.

The study was performed by Ontario researchers and published in the Canadian Medical Association Journal. Scientists concluded that Paxlovid helped prevent COVID-19-related fatalities during the rise of the Omicron variant, between April 4 and Aug. 31, 2022. Data from 8,876 patients treated with nirmatrelvir–ritonavir was compared with the records of 168,669 patients who were not treated with the medication. Most patients included in the research were older than 70 years of age and vaccinated.

"Our study, in conjunction with previous clinical trials and observational research, supports the effectiveness of nirmatrelvir–ritonavir at reducing hospital admission from COVID-19 and all-cause death," the study’s lead author, Dr. Kevin Schwartz, wrote in a press release. Schwartz is an infectious disease physician at St. Joseph’s Health Centre in Toronto.

Scientists discovered that for every 62 people treated with nirmatrelvir–ritonavir, one case of severe COVID-19 was prevented.

Schwartz added that, "this study highlights the importance of testing for SARS-CoV-2 if you have symptoms, and access to Paxlovid for those at risk for severe COVID-19.â€

A trial performed in the past also found that nirmatrelvir–ritonavir can be effective at treating patients with COVID-19, but that study did not involve patients who had been vaccinated or who had experienced possible drug–drug interactions.

“If you test positive for COVID-19, are over 60 years of age, or if you have other risk factors for severe infection, such as chronic medical conditions or are undervaccinated, contact your health care provider or pharmacy within five days of symptoms starting and ask about Paxlovid," Schwartz said.

Another , however, released by the UBC Therapeutics Initiative, found that Paxlovid offers no benefit to people who were at much lower risk of serious illness, when used for those with new-onset COVID-19 infections.

By assessing people with new onset COVID-19 infections who were treated with Paxlovid during 2022, the research found evidence of modest reductions in hospitalizations and severe illness. These people were compared to those with low risk for severe COVID-related complications who did not receive the drug.

The research found no evidence to suggest that Paxlovid reduces the likelihood of health complications for those who were not already at high risk for severe illness.

Colin Dormuth, an associate professor in UBC’s department of anaesthesiology, pharmacology, and therapeutics, said these findings lessen an urgency to receive the drug.

“The overall evidence shows there is no reason for lower risk people, including elderly people, to rush to obtain Paxlovid if they have COVID-19,†he said in a press release.

CTVNews.ca Top Stories

A team of tornado experts is heading to Fergus, Ont. after a storm ripped through the area Sunday night.

Why brain aging can vary dramatically between people

Researchers are uncovering deeper insights into how the human brain ages and what factors may be tied to healthier cognitive aging, including exercising, avoiding tobacco, speaking a second language or even playing a musical instrument.

Local Spotlight

For the second year in a row, the ‘Gift-a-Family’ campaign is hoping to make the holidays happier for children and families in need throughout Barrie.

Some of the most prolific photographers behind CTV Skywatch Pics of the Day use the medium for fun, therapy, and connection.

A young family from Codroy Valley, N.L., is happy to be on land and resting with their newborn daughter, Miley, after an overwhelming, yet exciting experience at sea.

As Connor Nijsse prepared to remove some old drywall during his garage renovation, he feared the worst.

A group of women in Chester, N.S., has been busy on the weekends making quilts – not for themselves, but for those in need.

A Vancouver artist whose streetside singing led to a chance encounter with one of the world's biggest musicians is encouraging aspiring performers to try their hand at busking.

Ten-thousand hand-knit poppies were taken from the Sanctuary Arts Centre and displayed on the fence surrounding the Dartmouth Cenotaph on Monday.

A Vancouver man is saying goodbye to his nine-to-five and embarking on a road trip from the Canadian Arctic to Antarctica.

Stay Connected